RSCM

Rock Springs Capital Management Portfolio holdings

AUM $1.6B
This Quarter Return
+10.4%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$1.97B
AUM Growth
+$1.97B
Cap. Flow
+$169M
Cap. Flow %
8.58%
Top 10 Hldgs %
27.38%
Holding
158
New
16
Increased
47
Reduced
16
Closed
10

Top Buys

1
MDT icon
Medtronic
MDT
$35.5M
2
UNH icon
UnitedHealth
UNH
$27.6M
3
AET
Aetna Inc
AET
$25.5M
4
MRSN icon
Mersana Therapeutics
MRSN
$21.3M
5
TMO icon
Thermo Fisher Scientific
TMO
$19.2M

Top Sells

1
LLY icon
Eli Lilly
LLY
$27.3M
2
SHPG
Shire pic
SHPG
$24.2M
3
BMY icon
Bristol-Myers Squibb
BMY
$22.4M
4
AMGN icon
Amgen
AMGN
$16.1M
5
PTHN
Patheon N.V.
PTHN
$10.5M

Sector Composition

1 Healthcare 80.21%
2 Financials 3.81%
3 Consumer Discretionary 1.14%
4 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
GBT
101
DELISTED
Global Blood Therapeutics, Inc.
GBT
$4.1M 0.21%
150,000
– –
OTIC
102
DELISTED
Otonomy, Inc.
OTIC
$3.96M 0.2%
210,000
– –
MGNX icon
103
MacroGenics
MGNX
$121M
$3.94M 0.2%
225,000
– –
ADAP
104
Adaptimmune Therapeutics
ADAP
$13.9M
$3.93M 0.2%
875,000
– –
HRC
105
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$3.58M 0.18%
45,000
– –
ALGN icon
106
Align Technology
ALGN
$9.59B
$3.45M 0.17%
+23,000
New +$3.45M
BLUE
107
DELISTED
bluebird bio
BLUE
$3.36M 0.17%
32,000
+1,500
+5% +$157K
CGEN icon
108
Compugen
CGEN
$133M
$3.14M 0.16%
825,000
– –
ALKS icon
109
Alkermes
ALKS
$4.95B
$3.01M 0.15%
52,000
-73,000
-58% -$4.23M
SIOX
110
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$2.9M 0.15%
+125,000
New +$2.9M
BMY icon
111
Bristol-Myers Squibb
BMY
$96.7B
$2.79M 0.14%
50,000
-402,600
-89% -$22.4M
RIGL icon
112
Rigel Pharmaceuticals
RIGL
$710M
$2.73M 0.14%
1,000,000
– –
ZBH icon
113
Zimmer Biomet
ZBH
$20.8B
$2.71M 0.14%
21,100
– –
DBVT
114
DBV Technologies
DBVT
$249M
$2.61M 0.13%
73,000
– –
GKOS icon
115
Glaukos
GKOS
$5.42B
$2.59M 0.13%
62,500
– –
INVA icon
116
Innoviva
INVA
$1.32B
$2.56M 0.13%
200,000
-35,000
-15% -$448K
HQY icon
117
HealthEquity
HQY
$8.26B
$2.54M 0.13%
51,000
+1,000
+2% +$49.8K
CBIO
118
Crescent Biopharma, Inc. Common Stock
CBIO
$184M
$2.51M 0.13%
+225,000
New +$2.51M
GNCA
119
DELISTED
Genocea Biosciences, Inc.
GNCA
$2.51M 0.13%
480,000
– –
MCRB icon
120
Seres Therapeutics
MCRB
$162M
$2.49M 0.13%
220,000
– –
ITCI
121
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$2.33M 0.12%
187,500
-2,500
-1% -$31.1K
CDTX icon
122
Cidara Therapeutics
CDTX
$1.61B
$2.25M 0.11%
300,000
– –
KA
123
DELISTED
Kineta, Inc. Common Stock
KA
$2.11M 0.11%
450,000
– –
ALDR
124
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
$2.08M 0.11%
182,000
– –
SYRE icon
125
Spyre Therapeutics
SYRE
$1.02B
$2.01M 0.1%
524,089
– –
3 4
5
6 7